| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.07▲ | 2.08▲ | 2.07▲ | 2.15▲ | 1.97▲ |
| MA10 | 2.01▲ | 2.02▲ | 2.02▲ | 2.06▲ | 2.01▲ |
| MA20 | 1.96▲ | 1.95▲ | 1.95▲ | 1.96▲ | 1.97▲ |
| MA50 | 1.94▲ | 1.98▲ | 1.99▲ | 2.01▲ | 2.08▲ |
| MA100 | 2.06▲ | 2.13▲ | 2.11▲ | 1.95▲ | 2.39▼ |
| MA200 | 2.16▲ | 2.06▲ | 2.02▲ | 2.00▲ | 2.93▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.027▲ | 0.032▲ | 0.033▲ | 0.041▲ | 0.025▲ |
| RSI | 67.491▲ | 64.525▲ | 64.117▲ | 64.866▲ | 55.543▲ |
| STOCH | 80.900▲ | 80.900▲ | 80.900▲ | 71.040 | 34.579 |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -23.585▲ | -41.713 |
| CCI | 248.100▲ | 246.988▲ | 246.988▲ | 136.139▲ | 113.443▲ |
|
Wednesday, April 30, 2025 12:27 AM
MARSEILLE, France I April 29, 2025 I Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today shared new preclinical data for ...
|
|
Tuesday, April 29, 2025 08:05 AM
MARSEILLE, France - Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA), a clinical-stage biotechnology company with a market capitalization of $182 million, has announced new preclinical data ...
|
|
Monday, April 28, 2025 05:00 PM
Innate Pharma Says It Filed Its 2023 Universa ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 2.215 | 2.34 | 2.1301 | 2.215 | 44,912 |
| 30/04/25 | 2.30 | 2.30 | 2.19 | 2.23 | 12,005 |
| 29/04/25 | 2.22 | 2.22 | 2.22 | 2.22 | 27,751 |
| 28/04/25 | 2.03 | 2.14 | 2.02 | 2.09 | 35,161 |
| 25/04/25 | 2.10 | 2.10 | 1.98 | 1.98 | 29,165 |
| 24/04/25 | 2.00 | 2.07 | 1.97 | 2.01 | 7,485 |
| 23/04/25 | 2.10 | 2.19 | 1.96 | 1.9955 | 61,236 |
| 22/04/25 | 1.92 | 1.96 | 1.8355 | 1.96 | 5,124 |
| 21/04/25 | 1.98 | 1.99 | 1.8551 | 1.93 | 12,601 |
| 17/04/25 | 1.96 | 1.99 | 1.96 | 1.97 | 4,306 |
|
|
||||
|
|
||||
|
|